Allen Klee
Stock Analyst at Maxim Group
(0.77)
# 3,633
Out of 4,814 analysts
62
Total ratings
23.33%
Success rate
-23.07%
Average return
Main Sectors:
Stocks Rated by Allen Klee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCEL Cryo-Cell International | Maintains: Buy | $9 → $8.5 | $5.85 | +45.30% | 2 | Mar 4, 2025 | |
| VSEE VSee Health | Initiates: Buy | $5 | $1.20 | +316.67% | 1 | Feb 24, 2025 | |
| INOD Innodata | Maintains: Buy | $54 → $75 | $33.05 | +126.93% | 2 | Feb 21, 2025 | |
| MITK Mitek Systems | Maintains: Buy | $13 → $14 | $7.67 | +82.53% | 4 | Feb 11, 2025 | |
| GIFT Giftify | Initiates: Buy | $4 | $1.80 | +122.22% | 1 | Feb 5, 2025 | |
| ORKT Orangekloud Technology | Initiates: Buy | $5 | $0.56 | +792.86% | 1 | Jan 30, 2025 | |
| IPM Intelligent Protection Management | Upgrades: Buy | $6 | $1.67 | +259.28% | 1 | Jan 14, 2025 | |
| HSCS HeartSciences | Reiterates: Buy | $12 | $3.10 | +287.10% | 3 | Dec 18, 2024 | |
| DLPN Dolphin Entertainment | Maintains: Buy | $8 → $5 | $1.02 | +390.20% | 4 | Nov 15, 2024 | |
| RDZN Roadzen | Maintains: Buy | $7 → $4 | $1.07 | +273.83% | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $3.61 | +121.61% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.67 | +347.89% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $15 | $2.96 | +406.76% | 2 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $2.79 | +115.44% | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $0.21 | +4,171.48% | 1 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.80 | - | 4 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 | $1.42 | +112.01% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.17 | +2,922.97% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.25 | - | 2 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.75 | +961.01% | 1 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $75 | $1.52 | +4,834.21% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $24 | $2.38 | +908.40% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $5.76 | +131.42% | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.49 | - | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $3.81 | +214.96% | 4 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $65 | $69.65 | -6.68% | 4 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.38 | - | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $132 | $3.12 | +4,137.56% | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $8.00 | - | 2 | Aug 2, 2017 |
Cryo-Cell International
Mar 4, 2025
Maintains: Buy
Price Target: $9 → $8.5
Current: $5.85
Upside: +45.30%
VSee Health
Feb 24, 2025
Initiates: Buy
Price Target: $5
Current: $1.20
Upside: +316.67%
Innodata
Feb 21, 2025
Maintains: Buy
Price Target: $54 → $75
Current: $33.05
Upside: +126.93%
Mitek Systems
Feb 11, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $7.67
Upside: +82.53%
Giftify
Feb 5, 2025
Initiates: Buy
Price Target: $4
Current: $1.80
Upside: +122.22%
Orangekloud Technology
Jan 30, 2025
Initiates: Buy
Price Target: $5
Current: $0.56
Upside: +792.86%
Intelligent Protection Management
Jan 14, 2025
Upgrades: Buy
Price Target: $6
Current: $1.67
Upside: +259.28%
HeartSciences
Dec 18, 2024
Reiterates: Buy
Price Target: $12
Current: $3.10
Upside: +287.10%
Dolphin Entertainment
Nov 15, 2024
Maintains: Buy
Price Target: $8 → $5
Current: $1.02
Upside: +390.20%
Roadzen
Nov 15, 2024
Maintains: Buy
Price Target: $7 → $4
Current: $1.07
Upside: +273.83%
Oct 31, 2024
Maintains: Buy
Price Target: $11 → $8
Current: $3.61
Upside: +121.61%
Oct 25, 2024
Initiates: Buy
Price Target: $3
Current: $0.67
Upside: +347.89%
Sep 27, 2024
Maintains: Buy
Price Target: $30 → $15
Current: $2.96
Upside: +406.76%
May 10, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $2.79
Upside: +115.44%
May 8, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $0.21
Upside: +4,171.48%
Apr 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.80
Upside: -
Mar 22, 2024
Upgrades: Buy
Price Target: $3
Current: $1.42
Upside: +112.01%
Dec 8, 2023
Initiates: Buy
Price Target: $5
Current: $0.17
Upside: +2,922.97%
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.25
Upside: -
Jul 28, 2023
Initiates: Buy
Price Target: $8
Current: $0.75
Upside: +961.01%
May 16, 2023
Maintains: Buy
Price Target: $150 → $75
Current: $1.52
Upside: +4,834.21%
Apr 3, 2023
Maintains: Buy
Price Target: $16 → $24
Current: $2.38
Upside: +908.40%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $13
Current: $5.76
Upside: +131.42%
Jan 25, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.49
Upside: -
Nov 16, 2021
Upgrades: Buy
Price Target: $12
Current: $3.81
Upside: +214.96%
Oct 29, 2021
Upgrades: Buy
Price Target: $65
Current: $69.65
Upside: -6.68%
Aug 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $11.38
Upside: -
Jun 2, 2021
Maintains: Buy
Price Target: $111 → $132
Current: $3.12
Upside: +4,137.56%
Aug 2, 2017
Upgrades: Buy
Price Target: n/a
Current: $8.00
Upside: -